About this course:
In this webinar series, Adam H. Fox, MD, MS, and Gerard A. Silvestri, MD, MS, Master FCCP, explore the topic of biomarker testing in advanced lung cancer. Their videos cover an introduction to biomarker testing and its illustrated improved outcomes; best practices for balancing diagnosis, staging, and tissue for testing; metrics of success/best practices and collaborations for biomarker testing programs; a new clinician checklist designed to enhance biomarker testing for patients with NSCLC; and more.
Course description:
Webinar #1:
Title: What Is Biomarker Testing for Advanced Lung Cancer and Why Is It Important?
Description: Get an introduction to biomarker testing and non-small cell lung cancer (NSCLC). Our experts define biomarker testing, discuss comprehensive testing, provide examples of therapies and local/metastatic indications for use based on trials/FDA approvals for early and advanced stage, and illustrate improved outcomes.
Moderator:
Adam H. Fox, MD, MS
Assistant Professor of Medicine
Division of Pulmonary and Critical Care Medicine
Medical University of South Carolina
Charleston, SC
Speaker: Bruce Johnson, MD
Institute Physician, Dana-Farber Cancer Institute
Professor of Medicine, Harvard Medical School
Webinar #2:
Title: Tissue Is the Issue: Using EBUS to Acquire and Process Tissue for Biomarker Testing for Advanced Lung Cancer
Description: Learn about best practices for balancing diagnosis, staging, and tissue for testing. Experts will discuss the role of EBUS and biomarker testing, success rates reported in the literature for different biopsy modalities, the role of ROSE, special scenarios (effusions, bone metes, brain mets, etc.), and considerations for QNS results: ct-DNA, re-biopsy.
Moderator:
Adam H. Fox, MD, MS
Assistant Professor of Medicine
Division of Pulmonary and Critical Care Medicine
Medical University of South Carolina
Charleston, SC
Webinar #3:
Title: Establishing a Program to Perform Lung Cancer Biomarker Testing: Shortening the Time From Patient Presentation to Treatment
Description: Understand metrics of success/best practices and collaborations for biomarker testing programs. Dr. Sholl covers tissue handling and pathology perspectives on turnaround time. Dr. Fox covers reflex testing and multidisciplinary coordination to improve turnaround time, as well as the role of biomarker testing for earlier stages of lung cancer.
Moderator:
Gerard A. Silvestri, MD, MS, Master FCCP
Hillenbrand Professor of Thoracic Oncology
Senior Vice-Chair of Faculty Development
Department of Medicine
Medical University of South Carolina
Charleston, SC
Speakers:
Lynette M. Sholl, MD
Department of Pathology
Brigham and Women's Hospital
Boston, MA
Adam H. Fox, MD, MS
Assistant Professor of Medicine
Division of Pulmonary and Critical Care Medicine
Medical University of South Carolina
Charleston, SC
Webinar #4:
Title: Enhancing NSCLC Biomarker Testing: Introducing a Practical Clinician Checklist
Description: In this CHEST webinar, Gerard A. Silvestri, MD, MS, and Adam H. Fox, MD, MS, unveiled a new clinician checklist designed to enhance biomarker testing for patients with non-small cell lung cancer (NSCLC). This informative session dove into the methodology employed to tackle practice gaps in tissue sampling, processing/testing, and interdisciplinary coordination. Learn how to leverage this practical checklist to improve patient care and outcomes, and discover ways to actively participate in quality improvement initiatives.